Search

everythinglearnresearchcommunity

for

Search:↓

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Nanozymes show promise for effective and safe cancer treatment.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Skin diseases differ between Ghana and the UK, with infections most common in Ghana and malignant skin diseases most prevalent in the UK.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Skin has specialized touch receptors that can tell different sensations apart.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Some common medications can harm male fertility, but many effects can be reversed.

Targeting the skin's endocannabinoid system could help treat skin disorders.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.